Research and Development

Clinical-stage biopharma firm Targacept has announced several changes to its Board of directors and management. By the end of May …

Ex-global head of Pfizer R&D and Pharmafocus regular John LaMattina has been given a strategic advisory role by biotech firm …

Merck KGaA is to begin a Phase IIb trial of its investigational drug sprifermin in patients with osteoarthritis (OA) of …

AstraZeneca is restructuring its global operations in a bid to improve the productivity of its R&D operations. The firm is …

Britannia Pharmaceuticals (part of the STADA Arzneimittel group of companies) has appointed Robert Wood as marketing director, for international markets. …

Drugs should be cheaper, GlaxoSmithKline boss Sir Andrew Witty said at a conference this week. His comments, reported by Reuters, …

Leading chemical firm BASF has made a series of appointments in order to reorganise its business operations. Strengthening the Asia-Pacific …

Merck is teaming up with Texas-based Luminex Corporation to develop a companion diagnostic to help in its dementia programme. The …

Johnson & Johnson has opened the doors to a new life sciences centre in London that forms part of a …

An ex-employee of research organisation Aptuit has been found guilty of changing pre-clinical trial data as part of a bid to …

The chairman of the Board of directors at Roche, Franz Humer, has announced that he will not stand for re-election …

 Dr Jim Hogan was speaking at the Prescriber and Pharmafocus conference: CCGs, the new NHS and Pharma in December.First of …

The NHS Commissioning Board has announced interim arrangements for the post of chief operating officer and deputy chief executive. Later …

Consolidation news in the CRO sector as Accelovance buys Radiant and PRA snaps up Clinstar, plus updates from Roche/BioLamina, PSI …

2012 saw German firm’s pharma division helping drive strong sales. Pharma revenue helped drive growth at Merck KGaA last year, with …